June 23, 2025

Central Body Fat Tied to Psoriasis Risk: Study

A large UK study of more than 336,000 adults found that central body fat, especially around the abdomen, was strongly linked to a higher risk of psoriasis, with the association more pronounced in women and independent of genetic risk.

Conexiant

June 23, 2025

What’s the Dose for Hair Regrowth?

A national survey found wide variation in intralesional corticosteroid injection techniques among US hair specialists treating different types of alopecia.

Conexiant

June 23, 2025

Psoriasis Biologics May Reduce Heart Risks

A large international study found that psoriasis patients treated with biologic therapies had a significantly lower risk of cardiovascular disease compared to those receiving oral treatments.

Conexiant

June 23, 2025

Methotrexate Adds No Psoriasis Benefit to Adalimumab

The addition of methotrexate to adalimumab for the treatment of plaque psoriasis may not improve drug survival, efficacy, or safety compared with adalimumab alone, according to a large real-world cohort study.

Conexiant

June 20, 2025

Multiple Biological Drivers Identified in Hair Graying

New research identifies oxidative stress, DNA damage, genetic variants, and stem cell depletion as key drivers of hair graying, with emerging therapies under investigation.

Conexiant

June 18, 2025

Are CBD Compounds Effective Antifungals?

CBD and CBDV exhibit antifungal activity against Cryptococcus neoformans and dermatophytes in vitro and improve survival in an in vivo model.

Conexiant

June 18, 2025

Is Pediatric Vitiligo Associated With Hearing, Retinal Risks?

Pediatric vitiligo was linked to higher risks of sensorineural and mixed hearing loss, with a short-term elevated risk of certain retinal abnormalities, according to a large US-based cohort analysis.

Conexiant

June 17, 2025

Avelumab Plus Cetuximab in Advanced Cutaneous Squamous Cell Carcinoma

In a phase II trial (Alliance A091802) reported in the Journal of Clinical Oncology, Zandberg et al investigated the survival benefit of adding cetuximab to avelumab in patients with advanced cutaneou...

The ASCO Post

June 16, 2025

Pathology Machine-Learning Models and Diagnosis of Nonmelanoma Skin Cancers in Resource-Limited Settings

Artificial intelligence (AI) models, which were pretrained on vast data sets, outperformed a standard baseline model in identifying nonmelanoma skin cancers from digital images of tissue samples, base...

The ASCO Post